Treatment options for sleep apnoea

Drugs

Volumn 61, Issue 2, 2001, Pages 237-251

  Grunstein, R R ^a   Hedner, J ^b   Grote, L ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIHYPERTENSIVE AGENT; CARBON DIOXIDE; FLUOXETINE; OXYGEN; PROTRIPTYLINE; SEROTONIN; SEROTONIN AGONIST; SEX HORMONE; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

DEVICE; DISEASE CLASSIFICATION; DRUG EFFICACY; FACE SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; QUALITY OF LIFE; REVIEW; SLEEP APNEA SYNDROME; TRACHEOSTOMY; UVULOPALATOPHARYNGOPLASTY;

EID: 0035093933     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161020-00007     Document Type: Review

References (100)

1. Pathogenesis of upper airway occlusion during sleep
2. Upper airway imaging in relation to obstructive sleep apnoea
3. Evidence for reflex upper airway dilator muscle activation by sudden negative airway pressure in man
4. The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans
5. Temperature thresholds in the oropharynx of patients with obstructive sleep apnoea syndrome
6. Central sleep apnoea
7. Recognition of obstructive sleep apnoea
8. The occurrence of sleepdisordered breathing among middle-aged adults
9. Snoring and sleep apnoea: A population study in Australian men
10. Snoring and sleep apnoea in men: Association with central obesity and hypertension
11. Impact of obstructive sleep apnoea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study
12. Size and mechanical properties of the pharynx in healthy men and women
13. The familial aggregation of obstructive sleep apnoea
14. Smoking as a risk factor for sleep-disordered breathing
15. Sleep apnoea in acromegaly
16. Obstructive sleep apnoea and blood pressure elevation: What is the relationship?
17. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats
18. Obstructive sleep apnoea as a cause of systemic hypertension: Evidence from a canine model
19. A specific and potent pressor effect of hypoxia in patients with sleep apnoea
20. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea
21. Obstructive sleep apnoea in patients with dilated cardiomyopathy: Effects of continuous positive airway pressure
22. Pulmonary hypertension in obstructive sleep apnoea
23. High prevalence of hypertension in sleep apnoea patients independent of obesity
24. Prospective study of the association between sleep-disordered breathing and hypertension
25. Mortality and apnoea index in obstructive sleep apnoea: Experience in 385 male patients
26. Association of sleep apnoea with myocardial infarction in men
27. Snoring, sleep apnoea syndrome, and stroke
28. Is obstructive sleep apnoea (OSA) a risk factor for myocardial infarction and cardiac arrhythmias in patients with coronary heart disease (CHD)?
29. Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnoea patients on nasal CPAP treatment
30. The sleep heart health study: Design, rationale, and methods
31. The association between sleep apnoea and the risk of traffic accidents: Cooperative Group Burgos-Santander
32. Treatment for snoring: Combined weight loss, sleeping on side, and nasal spray
33. Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects
34. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares
35. Sleep-related breathing disorders: 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea
36. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnoea/hypopnea syndrome
37. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnoea/Hypopnea syndrome
38. Feasibility of a self-setting CPAP machine
39. A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: Benefits, tolerance, compliance and quality of life
40. Obstructive sleep apnoea treated by in-dependently adjusted inspiratory and expiratory positive airway pressures via nasal mask: Physiologic and clinical implications
41. Oral appliances for the treatment of snoring and obstructive sleep apnoea: A review
42. Effects of submental electrical stimulation during sleep on upper airway patency in patients with obstructive sleep apnoea
43. Sleep fragmentation and daytime vigilance in patients with OSA treated by surgical maxillomandibular advancement compared to CPAP therapy
44. Surgical correction of anatomic abnormalities in obstructive sleep apnoea syndrome: Uvulopalatopharyngoplasty
45. Assessment of uvulopalatopharyngoplasty for the treatment of sleep apnoea syndrome
46. Uvulopalatopharyngoplasty in severe idiopathic obstructive sleep apnoea syndrome
47. Update on upper airway surgery for obstructive sleep apnoea
48. Sleep apnoea: A major public health problem [editorial; comment]
49. Protriptyline: An effective agent in the treatment of the narcolepsy- Cataplexy syndrome and hypersomnia
50. Protriptyline in obstructive sleep apnoea: A double-blind trial
51. Sleep apnoea: Treatment with protriptyline
52. The effects of protriptyline in sleep-disordered breathing
53. The effects of REM sleep deprivation on the level of sleepiness/alertness
54. Preliminary clinical experience with imipramine HCI in the treatment of sleep apnoea syndrome
55. Imipramine in sleep apnoea syndrome [in German]
56. L-tryptophan in the treatment of impaired respiration in sleep
57. Response of obstructive sleep apnoea to fluoxetine and protriptyline
58. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnoea
59. Central effects of 5-HT on respiratory and hypoglossal activities in the adult cat
60. The effects of serotonin antagonists in an animal model of sleep-disordered breathing
61. Upper airway muscle activity in normal women: Influence of hormonal status
62. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women
63. Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnoea
64. Indices of severity of obstructive sleep apnoea syndrome do not change during medroxyprogesterone acetate therapy
65. Effects of medroxyprogesterone acetate in obstructive sleep apnoea
66. Progesterone stimulates respiration through a central nervous system steroid receptor-mediated mechanism in cat
67. Effects of estrogen and progesterone on carotid body neural output responsiveness to hypoxia
68. Progesterone for outpatient treatment of Pickwickian syndrome
69. Respiratory insufficiency in postmenopausal women: Sustained improvement of gas exchange with short-term medroxyprogesterone acetate
70. Therapy control of theophylline evening dosage in patients with sleep-related respiratory disorders: Follow-up study
71. Comparative studies on the effect of nasal CPAP, theophylline and oxygen in patients with sleep apnea syndrome [in German]
72. Naloxone, theophylline, bromocriptine, and obstructive sleep apnoea: Negative results
73. The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnoea syndrome
74. Theophylline in obstructive sleep apnoea: A double-blind evaluation
75. Effects of theophylline on nocturnal sleep and daytime sleepiness/alertness
76. Effect of hypertension on upper airway function and sleep
77. An induced blood pressure rise does not alter upper airway resistance in sleeping humans
78. Hydralazine reduces elevated sleep apnoea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats
79. Influence of antihypertensive drug therapy on sleep pattern and sleep apnoea activity
80. Effect of clonidine in obstructive sleep apnoea
81. Sleep disturbances in hypertension: A double-blind study between isradipine and metoprolol
82. Cardiovascular effects of mibefradil in hypertensive patients with obstructive sleep apnoea
83. The effect of chronic nocturnal oxygen administration upon sleep apnoea
84. Alteration in obstructive apnoea pattern induced by changes in oxygen- and carbondioxide-inspired concentrations
85. Nicotine: A different approach to treatment of obstructive sleep apnoea
86. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleepdisordered breathing in nonsmokers
87. Benzodiazepine receptor antagonist (flumazenil) does not affect sleep-related breathing disorders
88. A double-blind, randomized trial of sabeluzole - A putative glutamate antagonist - In obstructive sleep apnea
89. Modafinil in obstructive sleep apnoea-hypopnea syndrome: A pilot study in 6 patients
90. Effect of octreotide, a somatostatin analog, on sleep apnoea in patients with acromegaly
91. Obstructive sleep apnoea in hypothyroidism
92. Myxedema and obstructive sleep apnoea
93. Association of hypothyroidism and obstructive sleep apnoea
94. Sleep apnoea and hypothyroidism: Mechanisms and management
95. Central sleep apnoea: Improvement with acetazolamide therapy
96. Central apnoea index decreases after prolonged treatment with acetazolamide
97. Central sleep apnoea after interrupting long term acetazolamide therapy
98. Effect of theophylline on sleep-disordered breathing in heart failure
99. Sleep apnoea in congestive heart failure
100. The effect of triazolam on arousal and respiration in central sleep apnoea patients